Phio Pharmaceuticals Corp. (PHIO) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PHIO Revenue Growth
PHIO Revenue Analysis (2014–2025)
As of May 8, 2026, Phio Pharmaceuticals Corp. (PHIO) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, PHIO's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $138,000 in 2018.
When compared to Healthcare sector peers including SRPT (-2.2% YoY), ARWR (+14.1% YoY), and ALNY (+82.6% YoY). Compare PHIO vs SRPT →
PHIO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PHIOCurrent | $0 | - | - | - | |
 SRPT | $2.2B | -2.2% | +32.4% | -29.9% | |
 ARWR | $829M | +14.1% | +56.6% | 11.9% | |
 ALNY | $3.7B | +82.6% | +49.8% | 13.5% | |
 NTLA | $68M | +16.9% | +3.1% | -651.7% | |
 BEAM | $140M | +108.0% | +466.3% | -274.6% |
PHIO Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $0 | - |
| 2024 | $0 | - | $-3,643,000 | - | $-7,387,000 | - |
| 2023 | $0 | - | $-6,332,000 | - | $-10,824,000 | - |
| 2022 | $0 | - | $-7,012,000 | - | $-11,462,000 | - |
| 2021 | $0 | - | $-8,886,000 | - | $-13,511,000 | - |
| 2020 | $0 | -100.0% | $-3,716,000 | - | $-8,793,000 | - |
| 2019 | $21K | -84.8% | $21K | 100.0% | $-8,987,000 | -42795.2% |
| 2018 | $138K | +820.0% | $-4,188,000 | -3034.8% | $-7,364,000 | -5336.2% |
| 2017 | $15K | -21.1% | $-5,355,000 | -35700.0% | $-14,062,000 | -93746.7% |
| 2016 | $19K | -44.1% | $-5,396,000 | -28400.0% | $-9,015,000 | -47447.4% |
See PHIO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PHIO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PHIO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPHIO — Frequently Asked Questions
Quick answers to the most common questions about buying PHIO stock.
Is PHIO's revenue growth accelerating or slowing?
PHIO TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is PHIO's long-term revenue growth rate?
Phio Pharmaceuticals Corp.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is PHIO's revenue distributed by segment?
PHIO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.